Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Cardiovascular Drugs Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
Cancer Cachexia Global Market Report 2024
... Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA Cancer Cachexia Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Cancer Treatment Drugs Companies in China
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Bladder Cancer Treatment Drugs Markets in China
... grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study ... Read More
-
Global Narcotics Scanner Market Analysis & Trends - Industry Forecast to 2030
... on our analysis the market is expected to grow at a CAGR of 10.5% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing include increasing sales across online channels, ... Read More
-
Global ePrescribing Market Analysis & Trends - Industry Forecast to 2030
... 2030. Some of the prominent trends that the market is witnessing include, increase in the adoption of integrated telehealth solutions, rising research and development of new technologies to improve the e-prescribing and adaptability & implementation ... Read More
-
Women Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, ORTHO TRI-CY LO (28)), By Application (Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome, Others), By Region and Competition, 2019-2029F
... Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome, Others), By Region and Competition, 2019-2029F Global Women Healthcare Market was valued at USD 9.52 Billion in 2023 and is anticipated to project steady growth in ... Read More
-
Global Trenbolone Enanthate Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Antacids Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Constipation Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... onset of the COVID-19 pandemic has led to a reduction in the number of patient visits that reduced the number of patients opting for constipation treatment, thereby impacting the market growth. However, at the onset, ... Read More
-
Inflammatory Bowel Disease (IBD) Therapeutics
... is expected to reach US$32.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. TNF inhibitors, one of the segments analyzed in the report, is expected to record a 5.9% ... Read More
-
Animal Medication
... at a CAGR of 4.6% over the analysis period 2023-2030. Companion Animals Medication, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$20.7 Billion by the end ... Read More
-
Compounding Pharmacies in the US - Industry Market Research Report
... the broader Healthcare and Social Assistance sector. Compounded medications can address patients' noncompliance with their medication by offering tastes, routes of administration and dosages that are not otherwise commercially available. The aging population has stimulated ... Read More
-
Human Reproductive Technologies
... by 2030, growing at a CAGR of 2.3% over the analysis period 2023-2030. Contraceptive Drugs & Devices, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$22.0 ... Read More
-
Bipolar Disorder Therapeutics
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by ... Read More
-
Cancer Cachexia
... at a CAGR of 5.6% over the analysis period 2023-2030. Progestogens Therapeutics, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Postpartum Hemorrhage (PPH) Treatment Devices
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a ... Read More
-
Scoliosis Management
... at a CAGR of 4.1% over the analysis period 2023-2030. Thoracolumbosacral Orthosis (TLSO), one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.9 Billion by the end ... Read More
-
Antidepressants
... of 2.5% over the analysis period 2023-2030. Antidepressants market for Major Depressive Disorder, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$7.0 Billion by the end ... Read More
-
Ophthalmic Pharmaceutical Drugs
... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Anti-VEGF Agents Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$34.3 ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
Cannabis Production in Canada - Industry Market Research Report
... Canada opened up medicinal cannabis production to more players in 2013, producers have grown continuously as they invest in production capabilities to produce quality products. As consumers shifted from illegal cannabis purchases to the licensed ... Read More
-
Antibacterial Drugs
... at a CAGR of 3.9% over the analysis period 2023-2030. ß-lactams Drug Class, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$35.4 Billion by the end ... Read More
-
Pediatric Drugs and Vaccines
... reach US$156.7 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Conjugate Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach ... Read More
-
e-Prescription Systems
... at a CAGR of 17.0% over the analysis period 2023-2030. e-Prescription Solutions, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$3.2 Billion by the end of ... Read More
Research Assistance
